So I manufacture something for a certain use. Someone thinks it may have another use. I strongly suggest for their own health they don't use it for that purpose, backed up by my scientific staff even though I could make a shitload more money for my investors. Why would I do that?
Someone asked this earlier in the thread and I added this as a response:
After a quick look in to it:
Buyers clamor for Merck's COVID-19 antiviral molnupiravir, but pricing is already controversial | FiercePharma
"The report cites an analysis by Harvard School of Public Health and King’s College Hospital in London, which found that it takes about $17.74 to produce a five-day course of molnupiravir. Earlier this year, Merck agreed to supply 1.7 million courses to the U.S. government at $700 each." (note: actually $712)
When you sell ivermectin, you are selling it to customers, normal people. The contracts are in place, the customers are paying a set amount that they have personal choice in. Its an established, mature market. But when you sell covid med, you're selling it to desperate governments, who get to splash around taxpayer money. Merck already has licensing agreements with 105 countries for molnupiravir. The US has already committed to purchasing $1.2 billion worth. Australia alone has paid for 300,000 doses. All at what looks like a massive premium.
But it gets even better. Because for Merck, they partnered with Ridgeback Biotherapeutics on developing the drug. Where did Ridgeback get their money? From federal funding provided under Trump (I'm assuming as part of Operation Warp Speed). So they didn't even have to spend most of the money it took to create it. They took money from the government to make something, then sell it back to the same government for billions in profit.
FYI I'm not an ivermectin guy, I have no idea if it does anything wrt covid. I'm also a fan of molnupiravir, because its been specially created and tested and could be a great tool in the fight against covid. But it is pretty easy to see that this could all be just very smart business by Merck. From a profit perspective if they assume covid remedies are gonna be needed for the next 5-10 years, having a pill that works better and makes them more money is a no brainer. And business decisions will guide which scientific studies are funded for which drugs, to prove or disprove their efficacy.






’